newsThe ABPI has said that the new UK-Japan free trade…
14 September 2020 | By Victoria Rees (European Pharmaceutical Review)
The ABPI has said that the new UK-Japan free trade agreement will benefit the pharma industry, providing continuity for life science businesses.